Buprenorphine and Office-Based Treatment of Opioid Dependence

Turnberry Isle Hotel Miami, Aventura, Florida

Saturday, December 10th 3:00pm-7:00pm

Program Overview

AAAP is sponsoring a workshop for physicians on the use of prescribing buprenorphine for the treatment of addiction of opiates. This training meets U.S. Department of Health and Human Services certification requirements for obtaining the waiver to prescribe buprenorphine. AAAP developed a new way of training which is called the “Half and Half” Course—3.75 hours of on-your-own-training and 4.25 hours of face-to-face training with an instructor. One “half” of the course is 3.75 hours of CD training containing modules that provide background in substance abuse treatment and specifically in treatment of opioid use disorders and use of buprenorphine. The CD should be reviewed before the face-to-face training. An examination on the CD is to be printed and completed and brought to the course director at the face-to-face training.

The other “half” of the course is a classroom-style training in a 4.25 hour face-to-face training with a course director who has already obtained the waiver to practice with buprenorphine and is doing so in his/her community. The training will focus on clinical vignettes to help trainees think through “real life” experiences in opioid use disorders treatment and will have several “overview” lectures that will provide a knowledge base neces­sary for this practice.

The combined face-to-face and CD training will provide the 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treat­ment of opioid use disorders.

Who Should Attend

This program is recommended for physicians with experience and/or interest in treating opioid use disorders. This program is also recommended for physicians in primary care, psychiatry, addiction medicine specialists and those treating HIV patients.

Buprenorphine Training Learning Objectives

  1. Identify the clinically-relevant pharmacological characteristics of buprenorphine
  2. Identify and incorporate specific resources to establish office-based treatment with buprenorphine for patients with opioid dependence
  3. Describe and contrast the functions of full agonists, partial agonists and antagonists
  4. Apply special treatment considerations with adolescent opioid-dependent patients and list factors to consider in evaluating a pregnant opioid-dependent woman
  5. Describe symptoms of opioid withdrawal or intoxication that mimic symptoms of a psychiatric disorder

Topics and Goals

  •      Overview of Office-Based Treatment of Substance Use Disorders           
  •      Review of Opioids          
  •      Introduction to Buprenorphine/Naloxone             
  •      Special Aspects of the treatment of Substance Use Disorders
  •      Special Treatment Populations and the Use of Buprenorphine

CME Credits

Continuing Medical Education credits will be available. More information coming soon.

Program Faculty

Elinore McCance-Katz, MD, PhD

Live Training Registration and Fees

  • Click Here to Register Online!
  • Students, Residents and Fellows: FREE
  • Non-Physicians/Related Health Professionals: $100.00
  • AAAP Members: $75.00
  • Non-Member Physicians: $100.00

Students, Residents and Fellows interested in attending for free: Registration cannot be completed online for this category.  Please fill out the PDF Registration Form , and fax to (401) 272-0922, or email to buptraining@aaap.org.